The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
Recruiting now · Not applicable
Conditions studied: Preterm Labor
In brief
The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).
Key facts
- Study ID
- NCT07305519
- Run by
- University of Roma La Sapienza
- People needed
- 150
- Starts
- 2026-04-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Signed informed consent
- Singleton pregnancy
- Maternal age ≥ 18 years
- Gestational age between 20+0 and 34+0 weeks at enrollment
- Cervical length between 15 mm and 30 mm measured by transvaginal ultrasound
You may not qualify if…
- Fetal structural anomalies
- Maternal chronic diseases or pregnancy-related conditions, including diabetes, hypertension, preeclampsia, cardiovascular disease, infections, or autoimmune disorders
- Multiple gestation
- Fetal growth abnormalities (estimated fetal weight <10th or >90th percentile)
- Prelabor rupture of membranes (PROM)
Where it is running
- Policlinico Umberto I — Rome, RM, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.